Wednesday, March 30th, 2016 - WiseGuyReports adds“Antibody Drug Conjugates Industry 2016 Global Market Research Report & Forecast to 2020”reports to its database. We can offer you discount on this report.

This market research study presents a detailed segmentation of the global antibody-drug conjugates market by mechanism of action (IgG1 antibodies and HER2 antibodies), by the technologies used (Seattle Genetics technology, ImmunoGen technology, and Immunomedics technology), and by geography (Americas, APAC, and EMEA). The key vendors in the market are F. Hoffmann-La Roche, Seattle Genetics, and Takeda Pharmaceuticals.

Outlook of the global antibody-drug conjugates (ADCs) market 
Technavio’s market research analysts have predicted the antibody-drug conjugates (ADCs) market to grow stupendously at a tremendous CAGR of more than 41% during the forecast period. Several products in the late-pipeline stage of clinical trials are expected to be launched over the predicted period which is expected to drive the growth prospects of this market. For instance, products like glembatumumab vedotin by Seattle Genetics, trastuzumab by Synthon Biopharmaceuticals are to be launched in the next five years. Moreover, some molecules are in Phase I/II, preclinical, and discovery stages. Altogether, there are several ADCs in the pipeline and their approval in the forecast period is expected to aid in the growth of this market.


For more information or any query mail at [email protected]

In this industry research report, the analysts have estimated factors like the emergence of targeted and combination therapies will positively affect this market over the coming years. Targeted therapies have fewer adverse effects than conventional non-targeted therapies as targeted therapies exploit the surface markers of infected cells, which are absent or in lower amounts in normal cells. For instance, around 20% of all breast cancer cases is associated with the overexpression of HER2. Therefore, drugs that target TER2 receptors are administered as monotherapies or in combination for such cancers. Targeting multiple pathways with ADC in diseases such as cancer reduces the risk of developing treatment-resistant disorders, thereby aiding in the growth of this market in the predicted period.

Segmentation by mechanism of action and analysis of the ADCs market 
- IgG1 antibodies 
- HER2 antibodies 
IgG is an antibody composed of four peptide chains and helps control the infection of tissues by binding to the pathogen such as virus, bacteria, and fungi. Moreover, these antibodies play an important role in intracellular antibody-mediated proteolysis and antibody dependent cell mediated toxicity. IgG1 find extensive applications in immunotherapy and drug development, thereby propelling the growth prospects of the ADCs market.

Geographical segmentation and analysis of the ADCs market 
- Americas 
In this industry report, the analysts have estimated that the Americas will dominate the global ADCs market until the end of 2020. This segment held the largest market share of more than 50% during 2015. The US was the largest revenue contributor in this region due to increasing incidences and prevalence of cancers.

Competitive landscape and key vendors 
The global ADCs market is highly competitive due to the presence of only three major providers in the market. The entry of new vendors is likely to intensify the competition, both in terms of innovation

and technology in the forecast period. The competitive environment is expected to increase in due to the product extensions, new products, and new applications of the products and services provided.


For more information or any query mail at [email protected]

Key vendors in this market are –

F. Hoffmann-La Roche 
Seattle Genetics 
Takeda Pharmaceuticals 
Other prominent vendors analyzed in this market research report are AbbVie, AbGenomics, ADC Therapeutics, Agensys, ALMAC Group, Ambrx, Astellas Pharma, AstraZeneca, Bayer Healthcare, CARBOGEN AMCIS, Celldex Therapeutics, Daiichi Sankyo, Endo Pharmaceuticals, Esperance Pharmaceuticals, Formation Biologics, Genmab, GlaxoSmithKline, Immunogen, Kairos Therapeutics, MedImmune, Mersana Therapeutics, Novartis, Oxford Biotherapeutics, Pfizer, Stemcentrx, Synthon Biopharmaceuticals, and Zymeworks.

Key questions answered in the report include 
- What will the market size and the growth rate be in 2020? 
- What are the key factors driving the global ADCs market? 
- What are the key market trends impacting the growth of the global ADCs market? 
- What are the challenges to market growth? 
- Who are the key vendors in the global ADCs market? 
- What are the market opportunities and threats faced by the vendors in the global ADCs market? 
- Trending factors influencing the market shares of the Americas, APAC, and EMEA. 
- What are the key outcomes of the five forces analysis of global ADCs market?


For more information or any query mail at [email protected]


Contact Profile


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Our Market Research Reports and Consulting Services 

Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. 

Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.

Norah Trent
P: +44 208 133 9349
M: +1 646 845 9349


Antibody Drug Conjugates, Antibody Drug Conjugates Industry, Antibody Drug Conjugates Market, Antibody Drug Conjugates Market Trend, Antibody Drug Conjugates Industry Trends, Antibody Drug Conjugates Market Share, Antibody Drug Conjugates Market Growth, A




More Formats